Past Events

UPDATED: Aetion pushes Series B to $82M as pandemic puts real-world evidence under the spotlight - Endpoints News
Former FDA chief Scott Gottlieb’s favorite real-world evidence platform is getting a new stream of cash, as it nears what will likely be the biggest test of the young company so far.
FDA In Brief: Findings from Real-World Data Study Reveal Higher Risk of Hospitalization and Death Among Cancer Patients with COVID-19, Underscore Health Disparities
The following quote is attributed to Harpreet Singh, M.D., Associate Director, Cancer in Older Adults and Special Populations, FDA’s Oncology Center of Excellence; and Director, Division of Oncology 2, FDA’s Center for Dru
FDA’s Ongoing Work to Support and Advance COVID-19 Diagnostic Test Accuracy and Availability
The U. S.
Industry Voices—How real-world EHR data are enhancing our understanding of COVID-19 - Fierce Healthcare
Traditionally, the healthcare industry has moved slowly when embracing new technology innovations.
FDA to Participate in Covid-19 Diagnostics Evidence Accelerator - Bloomberg Law
The FDA will participate in the Covid-19 Diagnostics Evidence Accelerator, a multi-stakeholder collaborative project organized by the Reagan-Udall Foundation for the FDA in collaboration with Frien
HAHN PLEDGES TO EVALUATE FUTURE OF DIAGNOSTICS REGULATION - POLITICO Prescription Pulse
At a Medical Device Innovation Consortium fireside chat Thursday, FDA Commissioner Stephen Hahn said the agency will take a fresh look at how it regulates diagnostics and digital technologies after the coronavirus pandemic
Pandemic pushes FDA to 'accelerate' real-world evidence efforts, Hahn says - MedTech Dive
FDA is upping efforts to incorporate real-world data in evaluation of COVID-19 diagnostics and antibody tests, 
FDA joins Reagan-Udall, Friends of Cancer Research to form COVID-19 Diagnostics Evidence Accelerator - The Cancer Letter
FDA is participating in the COVID-19 Diagnostics Evidence Accelerator, a multi-stakeholder collaborative project to advance the development of diagnostics.  The accelerator is organized by the Reagan-Udall Founda
Accelerating the fight against COVID-19 with real-world data on tests - BioCentury
Almost every aspect of the fight against COVID-19 depends on the ability to determine whether an individual is or has been infected with SARS-CoV-2, but more than six months into the pandemic there is still uncertainty abo
To expedite progress against COVID-19, a public-private “accelerator” taps into real-world data - The Cancer Letter
This story is part of The Cancer Letter’s ongoing coverage of COVID-19’s impact on oncology.